Cargando…

Efficacy of traditional Chinese medicine injections for treating idiopathic pulmonary fibrosis: A systematic review and network meta-analysis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF), acutely or slowly progressing into irreversible pulmonary disease, causes severe damage to patients’ lung functions, as well as death. In China, Chinese medicine injections (CMIs) have been generally combined with Western medicine (WM) to treat IPF, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shuai-yang, Cui, Hong-sheng, Lyu, Ming-sheng, Huang, Gui-rui, Hou, Dan, Yu, Ming-xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321402/ https://www.ncbi.nlm.nih.gov/pubmed/35881610 http://dx.doi.org/10.1371/journal.pone.0272047

Ejemplares similares

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis
por: Ji, Kun, et al.
Publicado: (2020)

Multiple Traditional Chinese Medicine interventions for idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Zhang, Hao-Yang, et al.
Publicado: (2020)

Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
por: Zhang, Yukun, et al.
Publicado: (2021)

Comparison of 4 kinds of traditional Chinese medicine injections to assist in improving clinical indicators of patients with idiopathic pulmonary fibrosis: A systematic review and network meta-analysis
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
por: Li, Liu-Cheng, et al.
Publicado: (2017)

Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population: A meta-analysis
por: Xiao, Shi-Hui, et al.
Publicado: (2018)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Traditional Chinese medicine in COVID-19
por: Lyu, Ming, et al.
Publicado: (2021)

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
por: Zhang, Kexiong, et al.
Publicado: (2021)

Comparative effectiveness of 3 Traditional Chinese Medicine treatment methods for idiopathic pulmonary fibrosis: A systematic review and network meta-analysis protocol
por: Pang, Li-Jian, et al.
Publicado: (2019)

Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial
por: Hailong, Zhang, et al.
Publicado: (2022)

The future of the development of medicines in idiopathic pulmonary fibrosis
por: Fregonese, Laura, et al.
Publicado: (2015)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Adjuvant Treatment of Crohn's Disease with Traditional Chinese Medicine: A Meta-Analysis
por: Wang, Yue, et al.
Publicado: (2019)

Research Progress in the Treatment of Idiopathic Membranous Nephropathy using Traditional Chinese Medicine
por: Lang, Rui, et al.
Publicado: (2020)

TCMSID: a simplified integrated database for drug discovery from traditional chinese medicine
por: Zhang, Liu-Xia, et al.
Publicado: (2022)

Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone
por: Jiang, Chun-guo, et al.
Publicado: (2019)

Effect of Traditional Chinese Medicine on the Cardiovascular Diseases
por: Jiang, Yang, et al.
Publicado: (2022)

Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese Children
por: Tan, Liping, et al.
Publicado: (2019)

Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)
por: DU, Hong-Zhi, et al.
Publicado: (2020)

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine
por: Tian, Rui, et al.
Publicado: (2023)

Lived experiences of the disease journey among patients with idiopathic pulmonary fibrosis
por: Lyu, Yang, et al.
Publicado: (2021)

Effects of Traditional Chinese Medicine Shuxuetong Injection on Random Skin Flap Survival in Rats
por: Cai, Leyi, et al.
Publicado: (2014)

Anti-Inflammatory and Immunomodulatory Effects of Paeonia Lactiflora Pall., a Traditional Chinese Herbal Medicine
por: He, Dong-Yi, et al.
Publicado: (2011)

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
por: Huang, Hui, et al.
Publicado: (2015)

Feasibility and Mechanism Analysis of Shenfu Injection in the Treatment of Idiopathic Pulmonary Fibrosis
por: Liu, Peipei, et al.
Publicado: (2021)

Development of chromatographic technologies for the quality control of Traditional Chinese Medicine in the Chinese Pharmacopoeia
por: Shen, Ming-Rui, et al.
Publicado: (2021)

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
por: Ren, Chunzhen, et al.
Publicado: (2022)

Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Li, Li-Juan, et al.
Publicado: (2020)

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
por: Shao, Rui, et al.
Publicado: (2019)

ETCM: an encyclopaedia of traditional Chinese medicine
por: Xu, Hai-Yu, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Combination of Traditional Chinese and Western Medicine in Sports in Pharmaceutical Health
por: Zhangyanhui,, et al.
Publicado: (2021)

Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
por: Álvarez, Diana, et al.
Publicado: (2015)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017)

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
por: Alonso-Gonzalez, Aitana, et al.
Publicado: (2023)

Molecular docking studies of Traditional Chinese Medicinal compounds against known protein targets to treat non-small cell lung carcinomas
por: Zhao, Guo-Fang, et al.
Publicado: (2016)

Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study
por: Wu, Wen-Jui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a2mpkoqnu2t561g11id5de9h4f